Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inventia Life Science is a biotechnology company specializing in advanced 3D bioprinting technology to revolutionize drug discovery and biomedical research. The company's flagship platform, RASTRUM, is a high-throughput 3D cell culture system that enables researchers to create complex, highly reproducible human tissue models at scale. By automating the printing of cells and matrix components, Inventia facilitates more accurate in vitro disease modeling and drug screening, particularly in oncology and regenerative medicine. Their technology aims to bridge the gap between traditional 2D cell cultures and animal models, providing more clinically relevant data earlier in the drug development process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inventa.